Table 4.
Organs | Cells | Printing Methods | Applications | References |
---|---|---|---|---|
Cardiovascular system | HUVECs, HASMC, HNDFB | Needle array printing system | Tissue regeneration | [43] |
miPSC-DC, HUVECs | Extrusion-based bioprinting | Tissue regeneration | [67] | |
hiPSC-DC, hCF | Scaffold-free bioprinting | Disease modeling | [125] | |
hiPSC-CS, hNDF | SWIFT (sacrificial writing into functional tissue) method | In vitro model Drug treatment screening |
[126] | |
C2C12, hESC-CM, CF | extrusion-based bioprinting | in vitro model | [127] | |
Liver | HepG2/C3A cells | Extrusion-based bioprinting | Drug toxicity testing | [131] |
hHep, hepatic stellate cells, HUVECs | Extrusion-based bioprinting | Drug toxicity testing. | [132] | |
HUVECs, hMSCs, hHep | Needle array printing system | Tissue regeneration | [134] | |
hHep, HUVECs, NHDF | Sacrificial bioprinting | Tissue regeneration | [135] | |
rHep, HUVEC, NHDF | Stereolithography | Tissue regeneration | [136] | |
Brain | rPeri, Astro, NSCs, bEnd.3 | Sacrificial bioprinting | In vitro model Drug treatment screening |
[137] |
hGlio, hAstro, microglia, HUVEC, PHMBP | Sacrificial bioprinting | In vitro 3D tumor model Drug treatment screening |
[140] | |
Skin | nHDF, nHEK, HMVEC | Extrusion-based bioprinting | Tissue regeneration | [142] |
hDF, Endo, Peri, Kera | Extrusion-based bioprinting | Tissue regeneration | [143] | |
hDF, hEK,, HUVECs, pre-adi | Extrusion-based bioprinting Sacrificial bioprinting |
in vitro model Drug treatment screening |
[144] | |
kidney | PTEC | Sacrificial bioprinting | Disease modeling Drug toxicity testing |
[147] |
PTEC, GMEC | Sacrificial bioprinting | Disease modeling Drug treatment screening |
[148] | |
PTEC, GMEC | Extrusion-based bioprinting with a core fugitive material | Tissue regeneration | [149] |
HUVEC = Human umbilical vein endothelial cells; HASMC = human aortic smooth muscle cells; HNDFB = human normal dermal fibroblasts; hiPSC-DC = hiPSC-derived cardiomyocytes; hCF = human cardiac fibroblasts; hiPSC-CS = hiPSC-derived cardiac spheroids; hNDF = human neonatal dermal fibroblasts; C2C12 (Mouse skeletal muscle cells); hESC-CM = hESC-derived cardiomyocytes; CF = cardiac fibroblasts; hHep = primary human Hepatocytes; NHDF = normal human dermal fibroblasts; rHep = primary rat hepatocytes; rPeri = Primary rat Pericytes; bEnd.3 (brain endothelial cell line); hGlio = Human glioblastoma cells; hAstro = Human astrocytes; PHMBP = primary human microvascular brain pericytes; nHDF = neonatal human dermal fibroblasts; nHEK = neonatal human epidermal keratinocytes; HMVEC = human dermal microvascular endothelial cells; hDF = human dermal fibroblasts; endo = endothelial cells; Peri = Pericytes; Kera = Keratinocytes; hEK = human epidermal keratinocytes; pre-Adi = pre-adipocytes, PTEC = human proximal tubule epithelial cells; GMEC = glomerular microvascular endothelial cells.